Literature DB >> 8256199

Conjugate vaccines: practice and theory.

R S Becker1.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8256199     DOI: 10.1007/bf00201102

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  55 in total

1.  Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.

Authors:  B A Claesson; B Trollfors; T Lagergard; J Taranger; D Bryla; G Otterman; T Cramton; Y Yang; C B Reimer; J B Robbins
Journal:  J Pediatr       Date:  1988-05       Impact factor: 4.406

Review 2.  The multifunctional role of C3, the third component of complement.

Authors:  J D Lambris
Journal:  Immunol Today       Date:  1988-12

3.  Bacteremia in children: an outpatient clinical review.

Authors:  P L McCarthy; G W Grundy; S Z Spiesel; T F Dolan
Journal:  Pediatrics       Date:  1976-06       Impact factor: 7.124

4.  High-density multiple antigen-peptide system for preparation of antipeptide antibodies.

Authors:  J P Tam
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

5.  Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.

Authors:  J J Donnelly; R R Deck; M A Liu
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

6.  Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of V kappa and V lambda segments and VJ combinations.

Authors:  E E Adderson; P G Shackelford; R A Insel; A Quinn; P M Wilson; W L Carroll
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

7.  The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.

Authors:  M Santosham; M Wolff; R Reid; M Hohenboken; M Bateman; J Goepp; M Cortese; D Sack; J Hill; W Newcomer
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

8.  Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide.

Authors:  E E Adderson; P G Shackelford; A Quinn; W L Carroll
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

9.  Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity.

Authors:  G J Noel; S Katz; P J Edelson
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

10.  Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens.

Authors:  E E Eynon; D C Parker
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  3 in total

1.  Role of the capsular polysaccharide-like serotype-specific antigen in resistance of Actinobacillus actinomycetemcomitans to phagocytosis by human polymorphonuclear leukocytes.

Authors:  N Yamaguchi; M Kawasaki; Y Yamashita; K Nakashima; T Koga
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

Review 2.  Use of licensed vaccines for active immunization of the immunocompromised host.

Authors:  L A Pirofski; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Synthesis, characterization and immunological properties of Escherichia coli 0157:H7 lipopolysaccharide- diphtheria toxoid conjugate vaccine.

Authors:  Shadi Rokhsartalab-Azar; Reza Shapouri; Mehdi Rahnema; Faezeh Najafzadeh; Anvarsadat Kianmehr
Journal:  Iran J Microbiol       Date:  2015-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.